As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Glycomics/Glycobiology Market: By Product: Enzymes, Kits, Reagents, Instruments; By Application: Drug Discovery & Development, Diagnostics, Others; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Glycomics/Glycobiology Market Outlook

The global glycomics/glycobiology market was valued at USD 913 million in 2020 and is expected to grow at a CAGR of 12% during the forecast period of 2021-2026.

 

The global glycomics/glycobiology market is being driven by the rising biotechnology industry. The market will receive a further impetus from the growth of the instruments segment.

 

Global Glycomics/Glycobiology Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Glycobiology is the study of carbohydrate structure, function, and biology, also known as glycans. Glycobiology is a fast-growing biological field of significance to biomedicine, biotechnology, and basic research.

The glycomics/glycobiology industry can be segmented into product, application, end-use, and region.

 

Global Glycomics/Glycobiology Market By End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on its end-uses, the glycomics/glycobiology market can be segmented as:

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)

Based on its products, the glycomics/glycobiology market can be divided into enzymes, kits, reagents, and instruments.

The enzymes are further subdivided into glycosidases, neuraminidases, glycosyltransferases, sialyltransferases, and others. Kits are divided into glycan labelling kits, glycan purification kits, glycan release kits, and other glycomics kits. Reagents are subdivided into glycoproteins, monosaccharides, and oligosaccharides. Instruments are also subdivided into HPLC, MALDI-TOF, array systems, and other instruments.

The EMR report looks into the regional glycomics/glycobiology markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Glycomics/Glycobiology Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The increasing focus on glycomics and proteomics research, increasing investment in R&D by research institutes and pharmaceutical and biotechnology companies, and technological advancements in glycomics instruments are the major drivers for the glycomics/glycobiology market growth. However, stringent government policies and regulations and the high cost of glycomics instruments are expected to hamper the growth of the glycomics/glycobiology market in the coming years.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global glycomics/glycobiology market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Thermo Fisher Scientific Inc.
  • Merck KGaA (OTCMKTS: MKKGY)
  • Agilent Technologies, Inc.
  • Bruker
  • New England Biolabs
  • Danaher
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Application, End Use, Region
Breakup by Product Enzymes, Kits, Reagents, Instruments
Breakup by Application Drug Discovery & Development, Diagnostics, Others
Breakup by End Use Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs)
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Bruker, New England Biolabs, Danaher, Shimadzu Corporation, Takara Bio Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Cost Structure
    4.5    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6    Global Glycomics/Glycobiology Market Analysis
    6.1    Global Glycomics/Glycobiology Market (2016-2020) & Forecast (2021-2026)
    6.2    Global Glycomics/Glycobiology Market Breakup by Product
        6.2.1    Enzymes
            6.2.1.1    Glycosidases
            6.2.1.2    Neuraminidases
            6.2.1.3    Glycosyltransferases
            6.2.1.4    Sialyltransferases
            6.2.1.5    Others
        6.2.2    Kits
            6.2.2.1    Glycan Labelling Kits
            6.2.2.2    Glycan Purification Kits
            6.2.2.3    Glycan Release Kits
            6.2.2.4    Other Glycomics Kits
        6.2.3    Reagents
            6.2.3.1    Glycoproteins
            6.2.3.2    Monosaccharides
            6.2.3.3    Oligosaccharides
            6.2.3.4    Others
        6.2.4    Instruments
            6.2.4.1    HPLC
            6.2.4.2    MALDI-TOF
            6.2.4.3    Array Systems
            6.2.4.4    Other Instruments
    6.3    Global Glycomics/Glycobiology Market Breakup by Product: Historical Market (2016-2020) & Forecast (2021-2026)
        6.3.1    Enzymes
            6.3.1.1    Glycosidases
            6.3.1.2    Neuraminidases
            6.3.1.3    Glycosyltransferases
            6.3.1.4    Sialyltransferases
            6.3.1.5    Others
        6.3.2    Kits
            6.3.2.1    Glycan Labelling Kits
            6.3.2.2    Glycan Purification Kits
            6.3.2.3    Glycan Release Kits
            6.3.2.4    Other Glycomics Kits
        6.3.3    Reagents
            6.3.3.1    Glycoproteins
            6.3.3.2    Monosaccharides
            6.3.3.3    Oligosaccharides
            6.3.3.4    Others
        6.3.4    Instruments
            6.3.4.1    HPLC
            6.3.4.2    MALDI-TOF
            6.3.4.3    Array Systems
            6.3.4.4    Other Instruments
    6.4    Global Glycomics/Glycobiology Market Breakup by Application
        6.4.1    Drug Discovery & Development
        6.4.2    Diagnostics
        6.4.3    Others
    6.5    Global Glycomics/Glycobiology Market Breakup by Application: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    Drug Discovery & Development
        6.5.2    Diagnostics
        6.5.3    Others
    6.6    Global Glycomics/Glycobiology Market Breakup by End Use
        6.6.1    Academic & Research Institutes
        6.6.2    Pharmaceutical & Biotechnology Companies
        6.6.3    Contract Research Organizations (CROs)
    6.7    Global Glycomics/Glycobiology Market Breakup by End Use: Historical Market (2016-2020) & Forecast (2021-2026)
        6.7.1    Academic & Research Institutes
        6.7.2    Pharmaceutical & Biotechnology Companies
        6.7.3    Contract Research Organizations (CROs)
    6.8    Global Glycomics/Glycobiology Market Breakup by Region
        6.8.1    North America
            6.8.1.1    United States of America
            6.8.1.2    Canada
        6.8.2    Europe
            6.8.2.1    Germany
            6.8.2.2    United Kingdom
            6.8.2.3    France
            6.8.2.4    Italy
            6.8.2.5    Others
        6.8.3    Asia Pacific
            6.8.3.1    China
            6.8.3.2    Japan
            6.8.3.3    India
            6.8.3.4    ASEAN
            6.8.3.5    Others
        6.8.4    Latin America
            6.8.4.1    Brazil
            6.8.4.2    Argentina
            6.8.4.3    Mexico
            6.8.4.4    Others
        6.8.5    Middle East & Africa
            6.8.5.1    Saudi Arabia
            6.8.5.2    United Arab Emirates
            6.8.5.3    Nigeria
            6.8.5.4    South Africa
            6.8.5.5    Others
    6.9    Global Glycomics/Glycobiology Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        6.9.1    North America
            6.9.1.1    United States of America
            6.9.1.2    Canada
        6.9.2    Europe
            6.9.2.1    Germany
            6.9.2.2    United Kingdom
            6.9.2.3    France
            6.9.2.4    Italy
            6.9.2.5    Others
        6.9.3    Asia Pacific
            6.9.3.1    China
            6.9.3.2    Japan
            6.9.3.3    India
            6.9.3.4    ASEAN
            6.9.3.5    Others
        6.9.4    Latin America
            6.9.4.1    Brazil
            6.9.4.2    Argentina
            6.9.4.3    Mexico
            6.9.4.4    Others
        6.9.5    Middle East & Africa
            6.9.5.1    Saudi Arabia
            6.9.5.2    United Arab Emirates
            6.9.5.3    Nigeria
            6.9.5.4    South Africa
            6.9.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis
    9.1    Thermo Fisher Scientific Inc.
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    Merck KGaA
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    Agilent Technologies, Inc.
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    Bruker
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    New England Biolabs
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Danaher
        9.6.1    Company Overview
        9.6.2    Financial Analysis
    9.7    Shimadzu Corporation
        9.7.1    Company Overview
        9.7.2    Financial Analysis
    9.8    Takara Bio Inc.
        9.8.1    Company Overview
        9.8.2    Financial Analysis
    9.9    Others
10    Industry Events and Developments

Key Questions Answered in the Report

In 2020, the global glycomics/glycobiology market attained a value of nearly USD 913 million.

The market is projected to grow at a CAGR of 12% between 2021 and 2026.

The major drivers of the market include rising biotechnology industry and the growth of the instruments segment.

Growing emphasis on research and development by key players is the key industry trend propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The end uses include academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs).

The technological segments are enzymes, kits, reagents, and instruments. Enzymes are further divided into glycosidases, neuraminidases, glycosyltransferases, and sialyltransferases, among others. Kits are further divided into glycan labelling kits, glycan purification kits, and glycan release kits, among other glycomics kits. Reagents can be further classified into glycoproteins, monosaccharides, and oligosaccharides, among others. Instruments are divided into HPLC, MALDI-TOF, and array systems, among other instruments.

The diverse applications for market include drug discovery and development and diagnostics, among others.

The major players in the industry are Thermo Fisher Scientific Inc., Merck KGaA (OTCMKTS: MKKGY), Agilent Technologies, Inc., Bruker, New England Biolabs, Danaher, Shimadzu Corporation, and Takara Bio Inc., among others.

Analyst Review

The global glycomics/glycobiology market attained a value of USD 913 million in 2020, driven by the biotechnology industry. Aided by the growing technological advancements, the market is expected to grow at a CAGR of 12% in the forecast period of 2021-2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The end-uses include academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs). The diverse applications for market include drug discovery and development and diagnostics, among others. The technological segments are enzymes, kits, reagents, and instruments. Enzymes are further divided into glycosidases, neuraminidases, glycosyltransferases, and sialyltransferases, among others. Kits are further divided into glycan labelling kits, glycan purification kits, and glycan release kits, among other glycomics kits. Reagents can be further classified into glycoproteins, monosaccharides, and oligosaccharides, among others. Instruments are divided into HPLC, MALDI-TOF, and array systems, among other instruments.The major regional markets for glycomics/glycobiology are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Thermo Fisher Scientific Inc., Merck KGaA (OTCMKTS: MKKGY), Agilent Technologies, Inc., Bruker, New England Biolabs, Danaher, Shimadzu Corporation, and Takara Bio Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER